Healthcare Quality, Patient Safety & PolicyXeris Biopharma Subsidiaries File Recorlev® LawsuitBusiness WireFebruary 27, 2026March 2, 2026 by Business WireFebruary 27, 2026March 2, 2026049 Four Orange Book Listed Patents through March 2040 Orphan Drug Exclusivity through December 2028 Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed...
